IRIS Accounts Production v24.3.2.46 07700771 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 763 1241 104197 4790 103668 4312 234 763 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh077007712023-07-31077007712024-07-31077007712023-08-012024-07-31077007712022-07-31077007712022-08-012023-07-31077007712023-07-3107700771ns15:EnglandWales2023-08-012024-07-3107700771ns14:PoundSterling2023-08-012024-07-3107700771ns10:Director12023-08-012024-07-3107700771ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3107700771ns10:SmallEntities2023-08-012024-07-3107700771ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3107700771ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3107700771ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3107700771ns10:FullAccounts2023-08-012024-07-3107700771ns10:OrdinaryShareClass12023-08-012024-07-3107700771ns10:OrdinaryShareClass22023-08-012024-07-3107700771ns10:OrdinaryShareClass32023-08-012024-07-3107700771ns10:OrdinaryShareClass42023-08-012024-07-3107700771ns10:Director2422023-07-3107700771ns10:Director2422022-07-3107700771ns10:Director2422023-08-012024-07-3107700771ns10:Director2422022-08-012023-07-3107700771ns10:Director2422024-07-3107700771ns10:Director2422023-07-3107700771ns5:CurrentFinancialInstruments2024-07-3107700771ns5:CurrentFinancialInstruments2023-07-3107700771ns5:ShareCapital2024-07-3107700771ns5:ShareCapital2023-07-3107700771ns10:RegisteredOffice2023-08-012024-07-3107700771ns5:FurnitureFittings2023-08-012024-07-3107700771ns5:MotorVehicles2023-08-012024-07-3107700771ns5:FurnitureFittings2023-07-3107700771ns5:MotorVehicles2023-07-3107700771ns5:FurnitureFittings2024-07-3107700771ns5:MotorVehicles2024-07-3107700771ns5:FurnitureFittings2023-07-3107700771ns5:MotorVehicles2023-07-3107700771ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3107700771ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-3107700771ns5:DeferredTaxation2023-07-3107700771ns5:DeferredTaxation2023-08-012024-07-3107700771ns5:DeferredTaxation2024-07-3107700771ns10:OrdinaryShareClass12024-07-3107700771ns10:OrdinaryShareClass22024-07-3107700771ns10:OrdinaryShareClass32024-07-3107700771ns10:OrdinaryShareClass42024-07-3107700771ns10:Director22023-08-012024-07-31077007711ns10:Director12023-07-31077007711ns10:Director12022-07-31077007711ns10:Director12023-08-012024-07-31077007711ns10:Director12022-08-012023-07-31077007711ns10:Director12024-07-31077007711ns10:Director12023-07-31
REGISTERED NUMBER: 07700771 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 July 2024

for

Pearce Urology Ltd

Pearce Urology Ltd (Registered number: 07700771)






Contents of the Financial Statements
for the Year Ended 31 July 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Pearce Urology Ltd (Registered number: 07700771)

Balance Sheet
31 July 2024

31.7.24 31.7.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 63,294 48,077

CURRENT ASSETS
Debtors 5 460,212 103,856
Investments 6 79,342 64,883
Cash at bank 71,243 242,219
610,797 410,958
CREDITORS
Amounts falling due within one year 7 26,925 16,830
NET CURRENT ASSETS 583,872 394,128
TOTAL ASSETS LESS CURRENT
LIABILITIES

647,166

442,205

PROVISIONS FOR LIABILITIES 8 12,026 736
NET ASSETS 635,140 441,469

CAPITAL AND RESERVES
Called up share capital 9 102 102
Retained earnings 635,038 441,367
SHAREHOLDERS' FUNDS 635,140 441,469

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pearce Urology Ltd (Registered number: 07700771)

Balance Sheet - continued
31 July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 January 2025 and were signed on its behalf by:





Dr I Pearce - Director


Pearce Urology Ltd (Registered number: 07700771)

Notes to the Financial Statements
for the Year Ended 31 July 2024

1. STATUTORY INFORMATION

Pearce Urology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07700771

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Motor vehicles - 15% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pearce Urology Ltd (Registered number: 07700771)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 4 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 August 2023 7,556 52,790 60,346
Additions 2,061 21,526 23,587
Disposals (3,178 ) - (3,178 )
At 31 July 2024 6,439 74,316 80,755
DEPRECIATION
At 1 August 2023 4,350 7,919 12,269
Charge for year 1,371 6,999 8,370
Eliminated on disposal (3,178 ) - (3,178 )
At 31 July 2024 2,543 14,918 17,461
NET BOOK VALUE
At 31 July 2024 3,896 59,398 63,294
At 31 July 2023 3,206 44,871 48,077

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Trade debtors - 1,833
Other debtors 460,212 100,212
S455 Tax - 1,811
460,212 103,856

6. CURRENT ASSET INVESTMENTS
31.7.24 31.7.23
£    £   
Listed investments 78,314 64,883
Unlisted investments 1,028 -
79,342 64,883
Market value of listed investments at 31 July 2024 - £ 78,314 (2023 - £ 64,883 ).

Pearce Urology Ltd (Registered number: 07700771)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Tax 25,491 16,067
Directors' current accounts 234 763
Accrued expenses 1,200 -
26,925 16,830

8. PROVISIONS FOR LIABILITIES
31.7.24 31.7.23
£    £   
Deferred tax 12,026 736

Deferred
tax
£   
Balance at 1 August 2023 736
Provided during year 11,290
Balance at 31 July 2024 12,026

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.7.23
value: £    £   
60 Ordinary A £1 60 60
40 Ordinary B £1 40 40
1 Ordinary C £1 1 1
1 Ordinary D £1 1 1
102 102

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 July 2024 and 31 July 2023:

31.7.24 31.7.23
£    £   
Dr I Pearce and Dr S Pearce
Balance outstanding at start of year (763 ) (1,241 )
Amounts advanced 104,197 4,790
Amounts repaid (103,668 ) (4,312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (234 ) (763 )

Pearce Urology Ltd (Registered number: 07700771)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

11. ULTIMATE CONTROLLING PARTY

The controlling party is Dr I Pearce.